Cell Cycle Checkpoint Control: The Cyclin G1/Mdm2/P53 Axis Emerges as a Strategic Target for Broad‑spectrum Cancer Gene Therapy - A Review of Molecular Mechanisms for Oncologists

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2018.1657
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Targeting P53-Mdm2-MDMX Loop for Cancer Therapy

Sub-Cellular Biochemistry
BiochemistryCancer ResearchCell BiologyMolecular Biology
2014English

P68 RNA Helicase as a Molecular Target for Cancer Therapy

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

P68 RNA Helicase as a Molecular Target for Cancer Therapy

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Cyclin D1 Is a Nuclear Protein Required for Cell Cycle Progression in G1.

Genes and Development
GeneticsDevelopmental Biology
1993English

Suppression of P53 by Notch3 Is Mediated by Cyclin G1 and Sustained by MDM2 and miR-221 Axis in Hepatocellular Carcinoma

Oncotarget
Oncology
2014English

Ribosomal Protein S27-Like and S27 Interplay With P53-Mdm2 Axis as a Target, a Substrate and a Regulator

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Molecular Pathways: The Necrosome—A Target for Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2016English

The AMPK-FoxO3A Axis as a Target for Cancer Treatment

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy